(Q40768279)

23 September 2017

0 references

Prognostic significance of p53 mutations in non-small cell lung cancer: a meta-analysis of 829 cases from eight published studies (English)

1 reference

23 September 2017

Huncharek M

1

1 reference

23 September 2017

Kupelnick B

series ordinal

2

1 reference

23 September 2017

Geschwind JF

series ordinal

3

1 reference

23 September 2017

Caubet JF

series ordinal

4

1 reference

23 September 2017

language of work or name

English

0 references

publication date

1 May 2000

1 reference

23 September 2017

1 reference

23 September 2017

volume

153

1 reference

23 September 2017

issue

1-2

1 reference

23 September 2017

page(s)

219-226

1 reference

Quantitative methods in the review of epidemiologic literature

23 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900381-5

7 January 2021

Mutations of the p53 Gene as a Predictor of Poor Prognosis in Patients With Non-Small-Cell Lung Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900381-5

7 January 2021

K-ras and p53 mutations are an independent unfavourable prognostic indicator in patients with non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900381-5

7 January 2021

Comparative analysis of p53 gene mutations and protein accumulation in human non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900381-5

7 January 2021

p53 exon 5 mutations as a prognostic indicator of shortened survival in non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900381-5

7 January 2021

TP53 mutational pattern in Spanish and Polish non-small cell lung cancer patients: null mutations are associated with poor prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900381-5

7 January 2021

Association between p53 mutation and clinicopathological features of non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900381-5

7 January 2021

p53 nuclear immunostaining and gene mutations in non-small-cell lung cancer and their effects on patient survival

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900381-5

7 January 2021

Clinicopathologic analysis of k-ras, p53, and ERBB-2 gene alterations in pulmonary adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900381-5

7 January 2021

Differential activation of target cellular promoters by p53 mutants with impaired apoptotic function

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900381-5

7 January 2021

p53: puzzle and paradigm

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900381-5

7 January 2021

Prognostic significance of TP53 alterations in breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900381-5

7 January 2021

Specific P53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2800%2900381-5

7 January 2021

10.1016/S0304-3835(00)00381-5

Identifiers

DOI

1 reference

23 September 2017

1 reference